Frequently Asked Questions
- When will NEMOS be available?
NEMOS is approved for the European market only.*
The device is available in Germany and Austria. Information on the availability in other European countries is available on request.
* All countries of the European Union and Switzerland
- How can I order NEMOS?
If you decide, with your consultant doctor, to apply the NEMOS therapy, you can order NEMOS directly from us (cerbomed GmbH). Your consultant doctor fills out a letter of recommendation for you, you sign a sales contract.
- How much does NEMOS cost?
The € 3,990 full price for NEMOS applies for a single payment. You can also buy NEMOS paying in monthly installments. If it can be verified that the patient does not respond sufficiently to the therapy, the device can be returned after 6 months. In this case, all payments made until the return will be refunded, less a basic charge of € 399. Please note: Treatment with NEMOS is currently not covered by health insurance companies.
- Am I suitable for t-VNS therapy with NEMOS?
We developed the NEMOS therapy for patients who suffer from drug-resistant epilepsy. You decide together with your consultant doctor whether this therapy is suitable for you. If your consultant doctor does not offer or know the therapy, please contact us. We will then contact your doctor, or can give you the details of a doctor who does offer this therapy. Contact form
The NEMOS device is not certified for treating patients during pregnancy, or for patients with active implants (such as a cardiac pacemaker, or a cochlear implant).
- How does NEMOS work?
The transcutaneous vagus nerve stimulator NEMOS consists of a stimulation unit and a dedicated ear electrode. The stimulation unit, having approximately the size of a common mobile phone, sends out the electrical impulses. It is connected with the ear electrode, which patients wear like an earphone. The impulses are transferred via the ear electrode through the skin to a branch of the vagus nerve.
- How often do I have to use NEMOS?
The treatment with NEMOS is carried out autonomously by patients in sessions lasting at least an hour, in 3 or 4 sessions a day, for a total of 4 to 5 hours per day.
- Which side effects may occur?
t-VNS is a therapeutic alternative with minor side effects. An analysis of data from over 300 patients and volunteers, who participated in studies of t-VNS, showed potential side effects that include itching, discomfort in the area of the outer ear and local pain at the stimulation side. These side effects usually disappear soon after stopping the stimulation.*
* Vigilance data cerbomed GmbH
- Can I stop using medications if I decide to use t-VNS?
t-VNS is a complementary therapy to medical treatment. Only your consultant doctor can decide whether you can stop or reduce medications.
- How long do I have to use t-VNS?
Like most pharmaceutical and neuromodulatory treatments for drug-resistant epilepsy, t-VNS is a long term therapy. You will get further information from your consultant doctor.
- How long does it take until the effect of t-VNS occurs?
Like most pharmaceutical and neuromodulatory treatments for drug-resistant epilepsy, t-VNS is not an acute therapy. Even if you respond to therapy with NEMOS, the effect may occur with a latency of some weeks to a few months.
- What can I do if I don’t respond to t-VNS?
Like in all other therapies there can never be a guarantee of success for a treatment using NEMOS. It is possible that some patients will not respond sufficiently to the therapy. Such patients can return the device after 6 months, for a partial refund of the purchase price.
NEMOS® - for treatment of drug-resistant epilepsy
Please download our brochure for patients and family.
Please note: NEMOS® is not cleared or approved for use in the U.S.